Paclitaxel has moderate activity in squamous cervix cancer. A Gynecologic Oncology Group study.
- 1 March 1996
- journal article
- clinical trial
- Published by American Society of Clinical Oncology (ASCO) in Journal of Clinical Oncology
- Vol. 14 (3), 792-795
- https://doi.org/10.1200/jco.1996.14.3.792